Genworth Financial Inc. jumped the most in almost two years after a U.S. national-security panel approved the $2.7 billion buyout of the company by China Oceanwide Holdings Group Co.
The Committee on Foreign Investment in the U.S., which reviews foreign acquisitions of American businesses, found “no unresolved national-security concerns” with the proposed deal, Genworth said Saturday.
That was “somewhat surprising,” given challenges other deals from Chinese buyers have faced, according to Tom Gallagher, an analyst at Evercore Partners Inc. At least 10 Chinese deals for U.S. firms have collapsed during the Trump administration amid security concerns raised by CFIUS.
The approval fueled a 26 percent gain in Genworth shares to $4.80 at 1:42 p.m. in New York, the biggest intraday increase since August 2016.
Top 5 China Stocks For 2019: Renesola Ltd.(SOL)
- [By Joseph Griffin]
These are some of the media headlines that may have impacted Accern’s scoring:
Get ReneSola alerts:
ReneSola Sells North Carolina Solar Project To Greenbacker (solarindustrymag.com) ReneSola (SOL) Rating Increased to Neutral at Roth Capital (americanbankingnews.com) ReneSola (SOL) Q1 Earnings in Line, Revenues Top Estimates (zacks.com) ReneSola’s (SOL) CEO Xianshou Li on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) ReneSola (SOL) Releases Earnings Results (americanbankingnews.com)
Shares of ReneSola traded up $0.08, hitting $2.76, during trading on Friday, Marketbeat.com reports. The stock had a trading volume of 124,969 shares, compared to its average volume of 108,565. The firm has a market capitalization of $102.11 million, a PE ratio of 21.23 and a beta of 2.05. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.36. ReneSola has a 12 month low of $2.12 and a 12 month high of $3.79.
Top 5 China Stocks For 2019: Netease.com Inc.(NTES)
- [By Shane Hupp]
News articles about NetEase (NASDAQ:NTES) have been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. NetEase earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned news coverage about the technology company an impact score of 47.5808045346287 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
- [By Max Byerly]
KAMES CAPITAL plc decreased its holdings in shares of NetEase (NASDAQ:NTES) by 68.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,800 shares of the technology company’s stock after selling 39,277 shares during the period. KAMES CAPITAL plc’s holdings in NetEase were worth $4,991,000 at the end of the most recent reporting period.
- [By Ethan Ryder]
Here are some of the news stories that may have effected Accern Sentiment’s rankings:
Get NetEase alerts:
NetEase Inc (NTES) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com) NetEase Inc (NTES) Sees Significant Growth in Short Interest (americanbankingnews.com) Hot Stock’s Trend Recap NetEase Inc (NASDAQ: NTES) (stockspen.com) Switching Three Stocks: The Procter & Gamble Company (NYSE:PG), NetEase, Inc. (NASDAQ:NTES), CBRE Group … (thestreetpoint.com) US benchmarks shake off G7 jitters, ending the day on a positive note (proactiveinvestors.co.uk)
A number of equities research analysts have issued reports on the stock. BidaskClub lowered shares of NetEase from a “hold” rating to a “sell” rating in a report on Tuesday, March 27th. Jefferies Financial Group cut their price target on shares of NetEase from $335.00 to $310.00 and set a “hold” rating on the stock in a report on Tuesday, April 10th. JPMorgan Chase & Co. assumed coverage on shares of NetEase in a report on Thursday, April 12th. They issued an “underweight” rating and a $240.00 price target on the stock. Zacks Investment Research raised shares of NetEase from a “sell” rating to a “hold” rating in a report on Thursday, March 8th. Finally, Daiwa Capital Markets raised shares of NetEase from a “neutral” rating to a “buy” rating in a report on Thursday, May 17th. Four research analysts have rated the stock with a sell rating, four have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $327.21.
- [By Leo Sun]
For comparison, Tencent (NASDAQOTH:TCEHY) and NetEase (NASDAQ:NTES), the two biggest names in Chinese mobile games, trade at about 9 times and 3 times this year’s sales, respectively. Out of the ten highest-grossing Android games in China (according to Newzoo’s April numbers), Tencent and its subsidiaries published six of the titles, while NetEase published three. The only game which didn’t come from those two publishers was 4399’s Dream Journey.
Top 5 China Stocks For 2019: Focus Media Holding Limited(FMCN)
- [By Stephan Byrd]
An issue of Focus Media Holding Limited (NASDAQ:FMCN) debt fell 1.1% against its face value during trading on Tuesday. The debt issue has a 7.5% coupon and is set to mature on April 1, 2025. The debt is now trading at $97.63 and was trading at $98.50 last week. Price changes in a company’s debt in credit markets sometimes anticipate parallel changes in its stock price.
Top 5 China Stocks For 2019: Top Image Systems Ltd.(TISA)
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Top Image Systems (TISA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 China Stocks For 2019: Clean Diesel Technologies Inc.(CDTI)
- [By Stephan Byrd]
Here are some of the media stories that may have impacted Accern Sentiment’s analysis:
Get Molecular Templates alerts:
Trading Center: Watching the Levels for Molecular Templates, Inc. (:MTEM): Move of 0.02 Since the Open (stocknewscaller.com) Molecular Templates (MTEM) Announces Clinical Data at 2018 ASCO Meeting (streetinsider.com) Gallbladder Cancer Treatment Sales Market Size by Players, Regions, Type, Application and Forecast to 2025 (exclusivereportage.com) ATR in spotlight EnSync, Inc. (NYSE:ESNC), CDTi Advanced Materials, Inc. (NASDAQ:CDTI), Molecular Templates, Inc … (stocksnewspoint.com)
MTEM has been the subject of several research analyst reports. ValuEngine lowered shares of Molecular Templates from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Zacks Investment Research raised shares of Molecular Templates from a “sell” rating to a “hold” rating in a research report on Thursday, June 7th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $5.20.